2024
Постійне посилання на фонд
Переглянути
Перегляд 2024 за Ключові слова "cognitive impairment"
Зараз показуємо 1 - 1 з 1
Результатів на сторінці
Налаштування сортування
Документ Cognitive and motor impairments in different motor subtypes of parkinson disease and patients’ quality of life(Полтавський державний медичний університет, 2024) Shkodina, A. D.; Шкодіна, Анастасія ДмитрівнаNumerous motor and non-motor symptoms characterize Parkinson's disease. Modern research increasingly focuses on their relationship and role in patients' quality of life. Our study aimed to evaluate cognitive and motor impairment in different motor subtypes of PD and analyze their relationship with quality of life. The study included 64 patients with Parkinson's disease, divided according to motor subtype: group 1 - patients with PD subtype with a predominance of postural instability and gait disorders; group 2 - patients with PD subtype with a predominance of tremor or intermediate subtype. The patients were examined using the Unified Parkinson's Disease Rating Scale, the Hoehn and Yahr scale, the Montreal Cognitive Assessment Scale, and the Parkinson's Disease Quality of Life Scale. It was found that group 1 had a statistically significant higher score on the "mobility" (p=0.004) and "emotional well-being" (p=0.013) scales, indicating a greater severity of motor function impairment and psychoemotional disorders in these patients. At the same time, the score on the "stigmatization" scale was found to be higher in group 2 (p=0.049). There were no differences in the scales of "daily activity", "social support", "cognition", "communication" and "body discomfort". The total score on the PDQ-39 scale was higher in group 1 compared to group 2 (p=0.042), indicating a worse quality of life. We found a worse quality of life in patients with PIGD subtype of PD, in particular in the domains of mobility and "emotional well-being", while patients with non-PIGD subtype were characterized by a more acute perception of disease stigma, in the absence of differences in the severity of clinical symptoms and cognitive impairment.